BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32448971)

  • 1. National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men.
    Doolin J; Reese ZA; Mukamal KJ
    World J Urol; 2021 Mar; 39(3):855-860. PubMed ID: 32448971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
    Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study.
    Patel DN; Feng T; Simon RM; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Roehrborn C; Andriole GL; Freedland SJ
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):238-244. PubMed ID: 29795141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Indian/Alaska Native men are less likely to receive prostate-specific antigen testing and digital rectal exams from primary care providers than White men: a secondary analysis of the National Ambulatory Medical Care Survey from 2012-2018.
    Gillette C; Locklear T; Bell R; Bates N; Ostermann J; Reuland D; Foley K; Lashmit C; Crandall S
    Cancer Causes Control; 2023 Sep; 34(9):749-756. PubMed ID: 37217700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Sutcliffe S; Grubb Iii RL; Platz EA; Ragard LR; Riley TL; Kazin SS; Hayes RB; Hsing AW; Andriole GL;
    BJU Int; 2012 Oct; 110(7):1050-9. PubMed ID: 22429766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management.
    Lerner LB; McVary KT; Barry MJ; Bixler BR; Dahm P; Das AK; Gandhi MC; Kaplan SA; Kohler TS; Martin L; Parsons JK; Roehrborn CG; Stoffel JT; Welliver C; Wilt TJ
    J Urol; 2021 Oct; 206(4):806-817. PubMed ID: 34384237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men.
    Stone BV; Shoag J; Halpern JA; Mittal S; Lewicki P; Golombos DM; Bedretdinova D; Chughtai B; Barbieri CE; Lee RK
    BJU Int; 2017 Feb; 119(2):298-304. PubMed ID: 27480499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia: clinical manifestations and evaluation.
    Santos Dias J
    Tech Vasc Interv Radiol; 2012 Dec; 15(4):265-9. PubMed ID: 23244722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting.
    Naslund MJ; Gilsenan AW; Midkiff KD; Bown A; Wolford ET; Wang J
    Int J Clin Pract; 2007 Sep; 61(9):1437-45. PubMed ID: 17686091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France].
    de la Taille A; Desgrandchamps F; Saussine C; Lukacs B; Haillot O
    Prog Urol; 2004 Jun; 14(3):320-5. PubMed ID: 15373173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of tools for objective evaluation of infravesical obstruction of men with lower urinary tract symptoms.
    Mazzariol O; Reis LO; Palma PR
    Int Braz J Urol; 2019; 45(4):775-781. PubMed ID: 31136110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of BPH and lower urinary tract symptoms in West Africans.
    Chokkalingam AP; Yeboah ED; Demarzo A; Netto G; Yu K; Biritwum RB; Tettey Y; Adjei A; Jadallah S; Li Y; Chu LW; Chia D; Niwa S; Partin A; Thompson IM; Roehrborn C; Hoover RN; Hsing AW
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):170-6. PubMed ID: 21912428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based guidelines for the management of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary.
    Spatafora S; Conti G; Perachino M; Casarico A; Mazzi G; Pappagallo GL;
    Curr Med Res Opin; 2007 Jul; 23(7):1715-32. PubMed ID: 17588302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Work-Up of Lower Urinary Tract Symptoms.
    Hecht SL; Hedges JC
    Urol Clin North Am; 2016 Aug; 43(3):299-309. PubMed ID: 27476123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.